Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
ablate, accomplish, ADNIC, affinity, AL, ANVISA, appealing, ascending, Asghar, Ashgar, attract, attracting, Brazil, Brazilian, BTK, career, CEO, CMO, cocktail, complex, composed, construct, cytokine, decoy, defunctionalize, distinct, DNA, dual, Education, eleven, employed, employment, ESPP, Foundation, gene, good, gradually, high, history, hub, ICU, immune, impede, intense, John, Jr, junior, lesser, loosening, lump, mab, man, master, Mayo, mesenchymal, middle, mild, moderate, motivate, motivating, Najjam, nanoparticle, post, PSC, rare, resolved, respiratory, RNA, safer, scientific, signaling, skilled, SmartPharm, SP, stem, storm, stromal, sum, syndrome, temporarily, tied, tightening, transient, transmission, turnover, vascular, Vice, withheld
Removed:
calendar, CEA, implantation, intrahepatic, intraperitoneal, leaving, malignant, noted, Sigma, studied, tumor, undelivered
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view